Kristin Stephens
Chief Development Officer · Syros Pharmaceuticals, Inc.
- 2024
- Nov 20, 2024
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Kristin Stephens. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nancy A. Simonian - $46K in SYRS purchases and sales on record
- Jason Haas - $29K in SYRS purchases and sales on record
- Conley Chee - $27K in SYRS purchases and sales on record
- Gerald E. Quirk - $10K in SYRS purchases and sales on record
- David Roth - $2K in SYRS purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristin Stephens?
Kristin Stephens is a corporate insider, tracked as Chief Development Officer of Syros Pharmaceuticals, Inc. (SYRS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kristin Stephens last file a Form 4?
The most recent primary Form 4 on record is dated 20 November 2024, one of 2 filings going back to 2024.
Has Kristin Stephens been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($8K) across all tracked filings.
